These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 24013413)
41. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues. Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885 [TBL] [Abstract][Full Text] [Related]
44. HU-331 is a catalytic inhibitor of topoisomerase IIα. Regal KM; Mercer SL; Deweese JE Chem Res Toxicol; 2014 Dec; 27(12):2044-51. PubMed ID: 25409338 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives. Na Y; Nam JM Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives. Vann KR; Ergün Y; Zencir S; Oncuoglu S; Osheroff N; Topcu Z Bioorg Med Chem Lett; 2016 Apr; 26(7):1809-12. PubMed ID: 26906637 [TBL] [Abstract][Full Text] [Related]
47. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives. Zhou Y; Xu X; Sun Y; Wang H; Sun H; You Q Bioorg Med Chem Lett; 2013 May; 23(10):2974-8. PubMed ID: 23566520 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of imidazopyridinyl-1,3,4-oxadiazole conjugates as apoptosis inducers and topoisomerase IIα inhibitors. Subba Rao AV; Vishnu Vardhan MV; Subba Reddy NV; Srinivasa Reddy T; Shaik SP; Bagul C; Kamal A Bioorg Chem; 2016 Dec; 69():7-19. PubMed ID: 27656775 [TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents. Thapa P; Kadayat TM; Park S; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES Bioorg Chem; 2016 Jun; 66():145-59. PubMed ID: 27174797 [TBL] [Abstract][Full Text] [Related]
50. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors. My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965 [TBL] [Abstract][Full Text] [Related]
51. D11, a novel glycosylated diphyllin derivative, exhibits potent anticancer activity by targeting topoisomerase IIα. Gui M; Shi DK; Huang M; Zhao Y; Sun QM; Zhang J; Chen Q; Feng JM; Liu CH; Li M; Li YX; Geng M; Ding J Invest New Drugs; 2011 Oct; 29(5):800-10. PubMed ID: 20336347 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression. Daumar P; Zeglis BM; Ramos N; Divilov V; Sevak KK; Pillarsetty N; Lewis JS Eur J Med Chem; 2014 Oct; 86():769-81. PubMed ID: 25240701 [TBL] [Abstract][Full Text] [Related]
53. A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships. Shrestha A; Park S; Jang HJ; Katila P; Shrestha R; Kwon Y; Lee ES Bioorg Med Chem; 2018 Oct; 26(18):5212-5223. PubMed ID: 30262132 [TBL] [Abstract][Full Text] [Related]
54. Discovery of mono- and disubstituted 1H-pyrazolo[3,4]pyrimidines and 9H-purines as catalytic inhibitors of human DNA topoisomerase IIα. Pogorelčnik B; Brvar M; Žegura B; Filipič M; Solmajer T; Perdih A ChemMedChem; 2015 Feb; 10(2):345-59. PubMed ID: 25522133 [TBL] [Abstract][Full Text] [Related]
55. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells. Patra N; De U; Kang JA; Kim JM; Ahn MY; Lee J; Jung JH; Chung HY; Moon HR; Kim HS Eur J Pharmacol; 2011 May; 658(2-3):98-107. PubMed ID: 21376033 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological evaluation of 4β-sulphonamido and 4β-[(4'-sulphonamido)benzamide]podophyllotoxins as DNA topoisomerase-IIα and apoptosis inducing agents. Kamal A; Suresh P; Ramaiah MJ; Mallareddy A; Imthiajali S; Pushpavalli SN; Lavanya A; Pal-Bhadra M Bioorg Med Chem; 2012 Mar; 20(6):2054-66. PubMed ID: 22364746 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and structure-activity relationships of hydroxylated and halogenated 2,4-diaryl benzofuro[3,2-b]pyridin-7-ols as selective topoisomerase IIα inhibitors. Thapa Magar TB; Hee Seo S; Shrestha A; Kim JA; Kunwar S; Bist G; Kwon Y; Lee ES Bioorg Chem; 2021 Jun; 111():104884. PubMed ID: 33872925 [TBL] [Abstract][Full Text] [Related]
58. Biological evaluation of a halogenated triterpenoid, 2α-bromo-dihydrobelulonic acid as inhibitor of human topoisomerase IIα and HeLa cell proliferation. Ghosh S; Mukhopadhyay S; Sarkar M; Mandal A; Das V; Kumar A; Giri B Chem Biol Interact; 2017 Apr; 268():68-76. PubMed ID: 28254521 [TBL] [Abstract][Full Text] [Related]
59. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies. Arjmand F; Yousuf I; Hadda Tb; Toupet L Eur J Med Chem; 2014 Jun; 81():76-88. PubMed ID: 24826817 [TBL] [Abstract][Full Text] [Related]
60. Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study. Woo S; Jung J; Lee C; Kwon Y; Na Y Bioorg Med Chem Lett; 2007 Mar; 17(5):1163-6. PubMed ID: 17194586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]